Cargando…

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma

Mesothelioma is characterised by its aggressive invasive behaviour, affecting the surrounding tissues of the pleura or peritoneum. We compared an invasive pleural model with a non-invasive subcutaneous model of mesothelioma and performed transcriptomic analyses on the tumour samples. Invasive pleura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orozco Morales, M. Lizeth, Rinaldi, Catherine A., de Jong, Emma, Lansley, Sally M., Lee, Y. C. Gary, Zemek, Rachael M., Bosco, Anthony, Lake, Richard A., Lesterhuis, W. Joost
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162533/ https://www.ncbi.nlm.nih.gov/pubmed/37146029 http://dx.doi.org/10.1371/journal.pone.0274364

Ejemplares similares

PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective
por: Orozco Morales, M. Lizeth, et al.
Publicado: (2021)

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
por: Zemek, Rachael M., et al.
Publicado: (2020)

Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy
por: Tilsed, Caitlin M., et al.
Publicado: (2022)

Catalysis-Enabled Access to Cryptic Geldanamycin Oxides
por: Hilton, Margaret J., et al.
Publicado: (2020)

A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential
por: Lansley, S. M., et al.
Publicado: (2016)

A New Geldanamycin Analogue from Streptomyces hygroscopicus
por: Zhang, Hao, et al.
Publicado: (2010)

Development of the first geldanamycin-based HSP90 degraders
por: Wurnig, Silas, et al.
Publicado: (2023)

Preclinical Models of Malignant Mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2020)

In Vitro Activity of Geldanamycin Derivatives against Schistosoma japonicum and Brugia malayi
por: Wenkert, David, et al.
Publicado: (2010)

Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii
por: Mout, Rubul, et al.
Publicado: (2012)

Geldanamycin Enhances Retrograde Transport of Shiga Toxin in HEp-2 Cells
por: Lingelem, Anne Berit Dyve, et al.
Publicado: (2015)

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
por: Chee, Jonathan, et al.
Publicado: (2018)

Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin
por: Liu, D, et al.
Publicado: (2002)

Geldanamycin Derivative Ameliorates High Fat Diet-Induced Renal Failure in Diabetes
por: Zhang, Hong-Mei, et al.
Publicado: (2012)

Fibronectin is a stress responsive gene regulated by HSF1 in response to geldanamycin
por: Dhanani, Karim Colin Hassan, et al.
Publicado: (2017)

What is Kindness in Science and why does it matter?
por: Boulter, Jessica, et al.
Publicado: (2022)

Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
por: Zemek, Rachael M., et al.
Publicado: (2022)

The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin
por: Kumar, Rajinder, et al.
Publicado: (2003)

Geldanamycin and Its Derivatives Inhibit the Growth of Myeloma Cells and Reduce the Expression of the MET Receptor
por: Jurczyszyn, Artur, et al.
Publicado: (2014)

HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells
por: Stankova, Katia, et al.
Publicado: (2015)

Streptomyces cameroonensis sp. nov., a Geldanamycin Producer That Promotes Theobroma cacao Growth
por: Boudjeko, Thaddée, et al.
Publicado: (2017)

Regulation of Geldanamycin Biosynthesis by Cluster-Situated Transcription Factors and the Master Regulator PhoP
por: Martín, Juan F., et al.
Publicado: (2019)

Anticancer activity and toxicity of new quaternary ammonium geldanamycin derivative salts and their mixtures with potentiators
por: Skrzypczak, Natalia, et al.
Publicado: (2021)

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations
por: Lesterhuis, W. Joost, et al.
Publicado: (2015)

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
por: Blanquart, Christophe, et al.
Publicado: (2020)

Use of preclinical models for malignant pleural mesothelioma
por: Shamseddin, Marie, et al.
Publicado: (2021)

Preclinical Assessment of Adjunctive tPA and DNase for Peritoneal Dialysis Associated Peritonitis
por: McGuire, Amanda L., et al.
Publicado: (2015)

Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells
por: Zhang, Zhirui, et al.
Publicado: (2016)

Synthesis and biological evaluation of geldanamycin–ferulic acid conjugate as a potent Hsp90 inhibitor
por: Li, Zhenyu, et al.
Publicado: (2019)

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations
por: Principe, Nicola, et al.
Publicado: (2022)

In Vivo Imaging of Human Malignant Mesothelioma Grown Orthotopically in the Peritoneal Cavity of Nude Mice
por: Feng, Mingqian, et al.
Publicado: (2011)

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma
por: Anobile, Dario P., et al.
Publicado: (2021)

Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing
por: Laure, Alexander, et al.
Publicado: (2023)

An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors – potential therapeutics in cancer and neurodegeneration
por: Kitson, Russell R. A., et al.
Publicado: (2013)

A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90
por: Palma, Luana Carneiro, et al.
Publicado: (2019)

Nigericin and Geldanamycin Are Phytotoxic Specialized Metabolites Produced by the Plant Pathogen Streptomyces sp. 11-1-2
por: Díaz-Cruz, Gustavo A., et al.
Publicado: (2022)

Study of interaction energies between residues of the active site of Hsp90 and geldanamycin analogues using quantum mechanics/molecular mechanics methods
por: Vivas-Reyes, Ricardo, et al.
Publicado: (2020)

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
por: Colvin, Emily K., et al.
Publicado: (2022)

Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
por: Tilsed, Caitlin M., et al.
Publicado: (2022)

LZY3016, a novel geldanamycin derivative, inhibits tumor growth in an MDA-MB-231 xenograft model
por: Li, Zhenyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5p9brdg5lfnrvdec4k56s50f6a